Govt extends 3% PRI to farmers for crop loans due to Covid-19 lockdown
Government is providing concessional crop loans to farmers through banks with 2% p.a. interest subvention to banks and 3% additional benefit on timely repayment to farmers thus providing loans upto Rs.3 lakh at 4% p.a. interest in timely repayment.
- Country:
- India
In the wake of lockdown due to ongoing Covid-19 pandemic, the Government has extended the benefit of 2% Interest Subvention (IS) to Banks and 3% Prompt Repayment Incentive (PRI) to all farmers upto 31st May 2020 for all crop loans upto Rs.3 lakh given by banks which have become due or are becoming due between 1st March 2020 and 31st May 2020.
Due to restrictions imposed on the movement of people, many farmers are not able to travel to bank branches for payment of their short term crop loan dues. Moreover, due to restrictions on the movement of people and difficulty in timely sale and receipt of payment of their produce, farmers may be facing difficulties in repayment of their short term crop loans falling due during this period.
To address this problem being faced by farmers, an extension of Interest Subvention (IS) and Prompt Repayment Incentive (PRI) benefit upto 31st May 2020 on the short term crop loans upto Rs.3 lakh which are due upto 31st May 2020, shall help the farmers to repay such loans upto the extended period at 4% p.a. interest without attracting any penalty.
Government is providing concessional crop loans to farmers through banks with 2% p.a. interest subvention to banks and 3% additional benefit on timely repayment to farmers thus providing loans upto Rs.3 lakh at 4% p.a. interest in timely repayment.
(With Inputs from PIB)
- READ MORE ON:
- Covid-19
- Prompt Repayment Incentive
- farmers
- lockdown
- crop loan
ALSO READ
My taxable income plummeted to Rs 680 in 2021-22 due to Covid-19 losses: BJP's Chandrasekhar
SC adjourns for July Ramdev's plea for clubbing of FIRs on his remarks on efficacy of allopathy to cure Covid-19
Report of workshop on COVID-19 vaccine strain updates held by ICMRA-WHO published
Health News Roundup: GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology; Gilead posts quarterly loss, revenue rises 5% and more
**Updated Headline:** **Secure Your COVID-19 Vaccine Certificate: A Comprehensive Guide to Download from Co-WIN, UMANG, and Aarogya Setu**